Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128566) titled 'Clinical Value of ¹8F-Florbetapir and 68Ga-FAPI-04 in the Prognostic Assessment of Light-Chain Cardiac Amyloidosi' on July 22.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Cardiac light-chain amyloidosis (AL-CA), heart failure, myocardial amyloid deposition, myocardial interstitial fibrosis, cardiac damage associated with plasma cell disorders
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-25
Target Sample Size: Patients with light-chain cardiac amyloidosis:80;
Countries of Recruitment:...